Acicaft Ophthalmic Solution 0.25%

Acicaft Ophthalmic Solution is an anti-allergic eye medication manufactured by ACI Limited, priced at ৳400.00 per unit. This 0.25% ophthalmic solution contains Alcaftadine, a dual-action H1 receptor antagonist and mast cell stabilizer. It effectively relieves itching linked to allergic conjunctivitis by blocking histamine and inhibiting inflammatory mediators.

Designed for adults and children aged 2+, the recommended dosage is one drop daily in each eye. As a topical ophthalmic solution, Acicaft works locally with minimal systemic absorption. Store below 25°C, shielded from light and moisture. Avoid contamination by not touching dropper tips.

Common side effects include transient burning, redness, or itching upon application. Rare instances of headaches or nasopharyngitis may occur. While classified as pregnancy category B, consult doctors before use during pregnancy/lactation. No overdose cases reported, but flush eyes with water if accidental excess occurs.

As an affordable alternative to pricier brands, Acicaft combines ACI Limited’s quality assurance with targeted allergy relief. Patients can purchase this 5ml bottle without prescription for immediate symptom management during allergy seasons.

Adults & children ≥2 years: 1 drop in each eye once daily. Remove contact lenses before use. Wait 5 minutes if using other eye drops. Avoid prolonged use without medical supervision.

The most frequent ocular reactions are eye irritation, burning or/and stinging upon instillation, eye redness and eye pruritus, nasopharyngitis and headache.

Pregnancy Category B: No risk in animal studies, but human safety unconfirmed. Unknown if excreted in breast milk. Consult doctor during lactation.

Avoid touching dropper tip to eyes/eyelids. Reinsert contact lenses 10 minutes after instillation. Keep bottle tip clean to prevent contamination. Monitor intraocular pressure with prolonged use.

Pediatrics (<2 years): Safety unestablished. Geriatrics: No specific precautions. Renal/Hepatic impairment: No dose adjustment data available.